Prescribing Patterns of Novel Oral Anticoagulants Following Regulatory Approval for Atrial Fibrillation in Ontario, Canada: A Population-Based Descriptive Analysis

CMAJ Open
doi 10.9778/cmajo.20130032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Joule Inc.

Related search

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2015English

Adherence and Persistence to Direct Oral Anticoagulants in Atrial Fibrillation: A Population-Based Study

Heart
Cardiovascular MedicineCardiology
2019English

PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER Study)

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2015English

Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2013English

Oral Anticoagulants and Atrial Fibrillation: A South African Perspective

South African Medical Journal
Medicine
2018English

Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

Novel Anticoagulants for Thromboembolic Complications Prevention in Nonvalvular Atrial Fibrillation

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

New Anticoagulants for Atrial Fibrillation

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy